Podcast: Play in new window | Download (19.5MB)
Subscribe: Spotify | iHeartRadio | Email | Deezer | RSS | More
Join StartUp Health NOW for a powerful episode recorded live at the Alzheimer’s Association International Conference (AAIC)! We explore the exciting inflection point in Alzheimer’s research fueled by AI and machine learning.
Hear directly from passionate founders in the StartUp Health Alzheimer’s Moonshot Community:
- Catherine Bornbaum, PhD, CBO at RetiSpec, fresh off the company’s $10M Series A, unveils a groundbreaking AI-powered device that analyzes the retina for insights into brain health.
- Ken Mariash, CEO of Sinaptica Therapeutics, discusses using AI and neuromodulation to potentially slow Alzheimer’s and strengthen brain function in healthy individuals.
Discover:
- How AI is unlocking a multi-modal understanding of the brain
- The potential for revolutionizing treatment for all brain conditions
- The cutting-edge technologies shaping the future of Alzheimer’s research
This episode is a must-listen for anyone passionate about brain health and the fight against Alzheimer’s!
Innovating in Alzheimer’s disease? Learn how you can join our Alzheimer’s Moonshot.
Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.
Funders: Become a Health Moonshot Champion